Abcellera Biologics Inc ABCL

$12.18 +1.06 (9.53%)

Valuation

Market cap
3,409,514,000
Revenue TTM
$75,130,000
Net income TTM
$-146,410,000
P/E (trailing)
0.00
P/E (forward)
—
Profit margin
-194.88%
Debt to equity
0.00

Trading

Volume
2,498,300
Avg volume
4,648,032
Day's range
$11.28 – $12.33
Shares out
306,611,000
Stochastic %K
40%
Beta
1.59
Analysts
Strong Buy
Price target
$17.17

Price

Company profile

AbCellera Biologics Inc. engages in discovering and developing antibody-based medicines for indications with unmet medical need in the United States. Its lead product is ABCL635, an non-hormonal medicine, which is in Phase 2 clinical trial to treat moderate-to-severe vasomotor symptoms; and ABCL575, a fully human, half-life extended monoclonal antibody, which is in in a Phase 1 clinical trial for treating T-cell-medi...

Show more

AbCellera Biologics Inc. engages in discovering and developing antibody-based medicines for indications with unmet medical need in the United States. Its lead product is ABCL635, an non-hormonal medicine, which is in Phase 2 clinical trial to treat moderate-to-severe vasomotor symptoms; and ABCL575, a fully human, half-life extended monoclonal antibody, which is in in a Phase 1 clinical trial for treating T-cell-mediated autoimmune conditions, such as atopic dermatitis. The company has a research collaboration and license agreement with Eli Lilly and Company; AbbVie Inc.; Jazz Pharmaceuticals plc to develop T-cell engaging (TCE) multispecific antibodies; partnership agreement with Viking Global Investors & ArrowMark Partners and Biogen Inc.; and Vertex Pharmaceuticals Incorporated to research, develop, manufacture, and commercialize multispecific T-cell engagers (TCEs) for autoimmune diseases and other conditions. AbCellera Biologics Inc. was incorporated in 2012 and is headquartered in Vancouver, Canada.

Industry
Biotechnology
Sector
Healthcare
Phone
604 559 9005
Website
https://www.abcellera.com
Address
150 W 4th Avenue, Vancouver, Canada

Latest news

Stocktwits

psyxopathis Nov 4, 10:40 AM
$ABCL whata going on and we jumped so much ?
0 replies
Stocktradesmoon Nov 4, 9:39 AM
$ABCL $MRNA $SYRE $REGN $SLS Money starting to Roll in as expected….ONLY THE BEGINNING!!!! $28 million upfront payment to AbCellera 🤑🤑🤑💰💰💰💰💵💵💵💵💵💵💸💸
1 replies
SCSyndrome Nov 4, 5:10 AM
$ABCL $NLST $RNXT $POET $LWLG Oil prices are down, 10 year yield is down stock futures are down for tomorrow.. anything up in this world?
4 replies
RosannaInvests Nov 4, 12:05 AM
5. AI + health The AI labs are walking into the lab. Literally. 🧪 Anthropic bought a one-person biotech that ran on Claude. A new startup raised $215M for AI-run robotic labs. Formation Bio launched a $600M fund to push AI-found drugs through trials. $TWST signed with Lilly's AI platform. AI floods the pipeline with candidates. The new chokepoints are data and trials. That's where $TEM (the data), $ABCL (the discovery engine) and $TWST (the DNA it's written in) sit. Compute is revenue. Biology is the next customer. 👀
0 replies
TopPi Nov 3, 10:09 PM
$YNVYF Watchlist: $YNVYF FDA ✅✅ regulatory pathway underway: Clinical studies of Sapphiros’ Digital Lateral Flow tests are underway. https://www.linkedin.com/posts/ynvisible_think-thinner-less-than-300-%CE%BCm-thick-our-activity-7480538681594957824-RR4Q This is a game changer for Ynvisible Marketcap: $6 million $ABCL Marketcap: $3.6 billion $REGN Marketcap: $99 billion $PLUG Marketcap: $1.8 billion $TLRY Marketcap: $376 million
0 replies
Stocktradesmoon Nov 3, 8:48 PM
$ABCL $REGN $MRNA $PFE $SLS $ABCL I’m sure that Carl and other team members of management are market buying today!!! Mark this post!! News After Hours today ahead of 3 Catalyst Events in a few days Starting WITH Earnings November 9!! I’ve seen this happen before and we get NEWS 🗞️ after hours that takes us to $15.00+
0 replies
Stocktradesmoon Nov 3, 8:38 PM
$ABCL $MRNA $REGN $SLS $PFE $ABCL 👀🔥 ABcellera 🔥!!! There is zero fundamental reason to support ABCL falling in price. If anything, the stock is too cheap right now. People don’t understand the sheer magnitude of what this company will do, and sadly those people will be left behind… I’m just sitting back with a boatload of shares waiting for the actual breakout to happen. We’ve seen nothing yet, IMO! Don’t get me wrong, I welcome sales in the market and will just keep buying but I don’t think we go anywhere but up…
0 replies
Stocktradesmoon Nov 3, 8:32 PM
$ABCL $PFE $MRNA $REGN $SLS
0 replies